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We report the design and synthesis of Ir-complex functionalized
CdSe/ZnS quantum dots (QDs), in which the QD plays a key
role in imaging, while the Ir-complex acts as a sensitizer to
produce singlet oxygen; this conceptual design presents a novel
scheme in both bio-imaging and photodynamic therapy.
Ligand-protected nanoparticles consisting of semiconductor cores
surrounded by organic monolayers have attracted considerable
interest for applications. The interest in these nanomaterials is
motivated by the unique optical and electrical properties of the
semiconductor cores induced by the quantum dot size effect, while
the organic surroundings can provide stability and additional
functionality. These unique properties have made them promising
nanomaterials for various potential applications including electro-
nics,1 optics,2 and biosensors.3 For biological application,
quantum dots possess several characteristics that make them
potential photosensitizers,4 and they have recently earned the
spotlight as imaging agents5 and diagnostics.6 As for the next stage
for the therapeutics, a technique known as photodynamic therapy
(PDT)7 has been attracting much attention. Studies have shown
that PDT can be as effective as surgery or radiation therapy in
treating certain kinds of cancers and precancerous conditions, and
may have some advantages: it is less invasive than surgery, it can
be targeted very precisely, and it can be repeated several times at
the same site if necessary, resulting in less blemishing. PDT
involves using a photosensitizing agent (or drug), which is
activated by being exposed to light, producing singlet oxygen to
destroy cancer cells. In view of exploiting semiconductor
nanoparticles in PDT, recent work by Samia5a and co-workers
reported that CdSe cores may be used directly to generate
singlet oxygen in toluene. However, the yield of singlet oxygen is as
low as y 5%, in comparison to ¢ 40% reported for classic
photosensitizers.
Herein, we report the conceptual design of a bifunctional
system, in which highly luminescent CdSe/ZnS quantum dots
(QDs) act as a visible imaging dye, while the third-row transition
metal complexes are attached and exploited as a photosensitizer.
The size of the CdSe core in CdSe/ZnS QDs can be strategically
fine-tuned, so that its emission locates at the low-lying triplet state
absorption of the transition metal complexes. Due to the forbidden
nature in the triplet manifold, the Fo¨rster type of resonance energy
transfer can be either drastically reduced or even eliminated, if one
can tune the thickness of ZnS and the length of the spacer between
QDs and the transition metal complex to a certain long distance.
Thus, the luminescent QDs provide the capability for imaging,
while the Ir complexes enhanced ultrafast intersystem crossing
guarantees unity population at the triplet states, consequently
inducing the sensitization of active molecular species, i.e., singlet
oxygen, that are toxic to cells and tissues.8,9
Scheme 1 depicts the synthetic route for the Ir–CdSe/ZnS QDs,
in which CdSe/ZnS QDs were prepared from CdO using a two-
step procedure reported previously.10 A detailed method of
preparing hydroxyl substituted pyridyl pyrazole ligand (L1) is
elaborated in the supporting information (SI). The first Ir-
complex, [(piq)2Ir(L1)], was synthesized via a reaction of
[(piq)2IrCl]2 and L1.
11 The thio-attached [(piq)2Ir(L1)], i.e.
[(piq)2Ir(L2)] (see Scheme 1), was synthesized from a mixture of
[(piq)2Ir(L1)] (100 mg, 0.125 mmol), thiotic acid (26 mg,
0.125 mmol), N,N9-dicyclohexylcarbodiimide (52 mg, 0.262 mmol)
aDepartment of Chemistry, National Taiwan University, Taipei 106,
Taiwan. E-mail: chop@ntu.edu.tw; Fax: +886 (2) 2369 5208;
Tel: +886 (2) 2364 3876 ext. 3988
bDepartment of Chemistry, National Tsing Hua University, Hsinchu
300, Taiwan. E-mail: ychi@mx.nthu.edu.tw
{ Electronic supplementary information (ESI) available: Detailed synth-
eses and characterization and measurements. See DOI: 10.1039/b517368j
Scheme 1 (i) NaOEt; (ii) N2H4; (iii) HCl; (iv) [(piq)2IrCl]2; (v) 1. thiotic
acid, DCC/DMAP, r.t., 72 h; 2. NaBH4, MeOH, r.t., 4 h; (vi)
[(piq)2Ir(L2)], Me4N(OH), pH = 11, MeOH, reflux, 24 h.
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and N,N9-dimethylamino pyridine (5 mg, 0.037 mmol) in CH2Cl2
(20 mL), followed by reduction using NaBH4. As for the synthesis
of [(piq)2Ir(L2)] encapsulated CdSe/ZnS QDs, namely Ir–CdSe/
ZnS, the tri-n-butylphosphine (TBP)/tri-n-octylphosphine oxide
(TOPO)-capped CdSe/ZnS QDs (10 mg) were dissolved in MeOH
(15 mL) containing [(piq)2Ir(L2)] (50 mg, 0.05 mmol) at a pH value
of y 12, adjusted with tetramethylammonium hydroxide
pentahydrate. The mixture was heated under reflux at 65 uC
overnight, and then the reaction was terminated and the mixture
allowed to cool to room temperature. Ir–CdSe/ZnS were then
precipitated with diethyl ether. For further purification, the crude
solid was washed with CH2Cl2 several times. Detailed synthetic
procedures and characterization in each intermediate step are
described in the supplementary information.
Characterization of Ir–CdSe/ZnS was first performed with IR
measurement. Figs. 1A and 1B depict the typical IR spectra of
neat [(piq)2Ir(L2)] and Ir–CdSe/ZnS. In comparison, the resem-
blance in both spectral features and peak positions for most
vibrational modes such as CLC (1450–1600 cm21) and CLN
stretching (y 2000 cm21) seems to guarantee a successful
attachment of [(piq)2Ir(L2)] onto CdSe/ZnS QDs. The absence
of S–H stretch band in the range of 2400–2600 cm21 in Fig. 1B
(see grey circle) firmly supports the formation of the sulfur–CdSe/
ZnS bond. The 1H NMR of Ir–CdSe/ZnS is shown in the ESI.
The associated 1H NMR peaks in Ir–CdSe/ZnS, except for the
missing S–H peak at d 1.5, are nearly identical to those of a pure
[(piq)2Ir(L2)] sample (also see ESI), further supporting the
attachment of [(piq)2Ir(L2)] on the surface of CdSe/ZnS.
Fig. 2 shows the absorption and emission spectra of
[(piq)2Ir(L2)] and Ir–CdSe/ZnS. The spectral assignment of
[(piq)2Ir(L2)] is straightforward, in which the lowest lying
transition, at 570–600 nm with the absorption extinction of
, 300 M21cm21, (see ESI) is assigned to the metal-to-ligand
charge transfer (MLCT) in the triplet manifold. For comparison,
the absorption of TOPO capped CdSe/ZnS QDs is also depicted; it
exhibited an emission peak at y 580 nm (not shown here) with a
quantum efficiency of y 0.42. Since Ir–CdSe/ZnS was prepared
via a ligand exchange process from the TOPO capped CdSe/ZnS
QDs, their similarity in size is expected. This viewpoint is
supported by the TEM results, in which the average diameters
of TOPO capped CdSe/ZnS and Ir–CdSe/ZnS, measured by
TEM, were calculated to be 6.8 ¡ 0.7 and 7.0 ¡ 0.6 nm,
respectively (see ESI). Since the diameter of the CdSe core was
measured to be y 3.8 nm, the thickness of ZnS was . 1.5 nm. As
shown in Fig. 2, the absorption spectrum of Ir–CdSe/ZnS is
apparently composed of the absorption profile of [(piq)2Ir(L2)]
and CdSe/ZnSe QDs. The steady state emission of Ir–CdSe/ZnS in
degassed MeOH consists of a distinct band maximized at 590 nm
and a shoulder around 650 nm. Upon aeration, the 650 nm
shoulder nearly disappeared, accompanied by a decrease of the
overall emission intensity (see Fig. 2). However, the 590 nm peak
position remained unchanged. In view of the spectral position and
bandwidth, the 590 nm emission profile resembles that (580 nm) of
the TOPO-capped CdSe/ZnS QDs. Thus, its assignment to the
CdSe/ZnS emission seems unambiguous. The y 10 nm red shift is
possibly due to the different capping environment, i.e. TOPO and
toluene versus [(piq)2Ir(L2)] and MeOH. Assuming that the
spectrum obtained in the aerated solution is mainly attributed to
the CdSe/ZnS emission, the spectrum acquired in the degassed
solution can thus be well convoluted by a combination of the
emission spectra of CdSe/ZnS (590 nm) and [(piq)2Ir(L2)] (610 nm).
These results clearly indicate that the 610 nm emission, which is
subject to drastic O2 quenching, is attributed to the phosphore-
scence of [(piq)2Ir(L2)]. Negligible interference (e.g. energy
transfer) between CdSe/ZnS and [(piq)2Ir(L2)] chromophores is
supported by the following experimental data. Upon monitoring
at the emission wavelength of y 750 nm, which solely originates
from the [(piq)2Ir(L2)] emission, the excitation spectrum is identical
with the absorption profile of the QDs-free [(piq)2Ir(L2)].
Furthermore, upon monitoring at e.g. 600 nm, the relaxation
dynamics of Ir–CdSe/ZnS in degassed MeOH were composed of a
fast component and a much slower decay component, the lifetimes
of which were fitted to be 32 ns and 2.1 ms, respectively. Upon
aeration, the 2.1 ms component was drastically reduced toy 200 ns,
while the fast component remained unchanged in either pre-
exponential or decay time (i.e. y 30 ns, see Fig. 3). One can thus
safely conclude that the Fo¨rster type of resonance energy transfer is
either very minor or even not operative in the Ir–CdSe/ZnS system.
The generation of 1O2 in the Ir–CdSe/ZnS system was
supported by the observation of 1Dg (0) A 1S2g (0) 1273 nm
Fig. 1 FT-IR spectra of pure [(piq)2Ir(L2)] (A) and the [(piq)2Ir(L2)]-
capped CdSe/ZnS QDs (B).
Fig. 2 Absorption and emission spectra of Ir-complex (blue) and Ir–
CdSe/ZnS QDs (grey for degassed, black for aerated) in MeOH; (red)
absorption spectra of TOPO-capped CdSe/ZnS in toluene.
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emission upon exciting Ir–CdSe/ZnS in the aerated MeOH (see
insert of Fig. 3). The assignment of 1O2 emission is unambiguous
based on two observations. First, this 1273 nm emission
disappeared upon degassing. Secondly, the lifetime of the emission
revealed drastic solvent isotope dependence, being shifted from
25 ms in MeOH to y 240 ms in CD3OD, consistent with a
1O2
electronic transition-solvent vibrational energy matching mechan-
ism.12 We further made an attempt to estimate the yield of 1O2
1Dg (0) A 1S2g (0) 1273 nm emission. In this approach, the
compound bis(triisobutylsiloxy) silicon-2,3-naphthalocyanine
(SiINC) was used as a reference, of which the 1342 nm
phosphorescence yield has been determined to be 7.47 6 1025
in benzene.13 Under experimental conditions where the number of
photons being absorbed by the Ir–CdSe/ZnS and SiINC are
identical at e.g. 600 nm, the relative quantum yield of the 1O2
phosphorescence in MeOH with respect to that of the SiINC
phosphorescence in THF was calculated on the basis of the
following relationship
w Tð ÞTHF
w 1Dg
 
MeOH
~
Ð
n2THF FT ~uð Þd~uÐ
n2MeOH F1O2
~uð Þd~u
where FT ~uð Þ and F1O2 ~uð Þ are the phosphorescence spectra of
SiINC and O2 (
1Dg), respectively. n denotes the refraction index of
the solvent, which is 1.328 for MeOH and 1.401 for THF.14 As a
result, the quantum yield of O2 (
1Dg) 1273 nm emission was
calculated to be 4.16 1025 in MeOH. This value is y 87% of the
1O2 sensitized by 1H-phenalen-1-one (PH) in the MeOH (y 4.76
1025).15 Since the efficiency of PH sensitizing 1O2 in aerated
solution is near unity,15b it is reasonable to conclude that the 1O2
production is y 87% for Ir–CdSe/ZnS. In aerated MeOH, since
the decay dynamics of Ir–CdSe/ZnS phosphorescence are
dominated by the O2 quenching process (see Fig. 3), the O2
quenching efficiency is thus nearly equivalent to the ratio of
[kaer (5 6 10
6 s21) 2 kdegas (4.76 6 10
5 s21)] versus kaer and was
estimated to be 90%. As a result, the efficiency of the 1O2
production is deduced to be as high as 97%.
In conclusion, we have ingeniously designed an Ir–CdSe/ZnS
system, in which the interplay between CdSe/ZnS QDs and
[(piq)2Ir(L2)] chromophores is negligible. The system possesses a
bifunctional property in that CdSe/ZnS QDs and [(piq)2Ir(L2)] act
as an imaging center and a 1O2 sensitizing agent, respectively. For
Ir–CdSe/ZnS in aerated MeOH, the quantum yield of the 590 nm
CdSe/ZnS emission was determined to be 0.4, which is sufficiently
high for application in imaging. As the next practical application,
specific target agents can also be designed and co-anchored with
[(piq)2Ir(L2)] ligand to CdSe/ZnS, among which a potential
candidate should be folic acid because it binds to a receptor that
several kinds of cancer cells produce in unusually large amounts.16
The resulting system is expected to be water soluble as well as to
possess a three-in-one property, namely specific targeting, imaging,
and 1O2 generation, which would greatly expand the usefulness of
photodynamic therapy.
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